Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Toxicol Lett ; 396: 28-33, 2024 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-38642675

RESUMO

The aerotoxic syndrome has been associated with exposure to tricresyl phosphate (TCP), which is used as additive in hydraulic fluids and engine lubricants. The toxic metabolite 2-(2-cresyl)-4H-1,3,2-benzodioxaphosphorin-2-oxide (CBDP) is formed from the TCP isomer tri-ortho-cresyl phosphate (TOCP) in vivo and is known to react with the active site serine in acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) resulting in the inhibition of the enzymes. Previous in vitro studies showed pronounced species differences in the inhibition kinetics of cholinesterases by organophosphorus compounds (OP), which must be considered in the development of relevant animal models for the investigation of OP poisoning and the aerotoxic syndrome. The present study was designed to investigate the inhibition kinetics of human, Cynomolgus monkey, pig, mini pig, guinea pig, mouse, and rat AChE as well as BChE by CBDP under standardized conditions. There were similar rate constants for the inhibition (ki) of human, Cynomolgus monkey and mouse AChE by CBDP. In contrast, the ki values obtained for guinea pig, mini pig, pig, and rat AChE were 2.8- to 5.9-fold lower than that of human AChE. The results of the present study confirmed CBDP as one of the most potent inhibitors of human BChE, indicating a ki value of 3.24 ± 0.33 ×108M-1min-1, which was about 1,140-fold higher than that of human AChE. Accordingly, a markedly more pronounced inhibition rate of BChE from the species guinea pig, mini pig, pig, rat, Cynomolgus monkey, and mouse by CBDP was found as compared to those of AChE from the respective sources, indicating 2.0- to 89.6-fold higher ki values.


Assuntos
Acetilcolinesterase , Butirilcolinesterase , Inibidores da Colinesterase , Macaca fascicularis , Compostos Organofosforados , Especificidade da Espécie , Porco Miniatura , Animais , Butirilcolinesterase/metabolismo , Inibidores da Colinesterase/toxicidade , Inibidores da Colinesterase/química , Acetilcolinesterase/metabolismo , Cobaias , Camundongos , Ratos , Humanos , Compostos Organofosforados/toxicidade , Cinética , Suínos
2.
Curr Comput Aided Drug Des ; 15(1): 104-109, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-29968541

RESUMO

INTRODUCTION: Irreversible inhibition of the acetylcholinesterase upon intoxication with organophosphorus compounds leads to an accumulation of acetylcholine in the synaptic cleft and a subsequent desensitization of nicotinic acetylcholine receptors which may ultimately result in respiratory failure. A direct intervention at the nicotinic acetylcholine receptor (nAChR) was proposed as an alternative therapeutic approach to the treatment with atropine and oximes. METHODS: The bispyridinium compound MB327 has been found to recover functional activity of nAChR thus representing a promising starting point for the development of new drugs for the treatment of organophosphate poisoning. Recent solid-supported membrane-based electrophysiological experiments have identified symmetrically substituted bispyridinium compounds e.g. MB327, MB583, and PTM0001 that are able to resensitize nAChR of Torpedo californica. In addition, six compounds have been found not to show any resensitizing potential and were thus classified as inactive. This set of active and inactive bispyridinium compounds was taken to develop a pharmacophore model and in silico screening of a virtual database of bispyridinium compounds to identify new compounds that are able to restore the functional activity of desensitized nAChR. RESULTS: Screening of a virtual compound database of symmetrically substituted bispyridinium compounds with the derived pharmacophore yielded several promising compounds which satisfy the pharmacophore and ought to have the same or even better resensitizing effect on nAChR as the parent compound MB327.


Assuntos
Intoxicação por Organofosfatos/tratamento farmacológico , Receptores Nicotínicos/metabolismo , Simulação por Computador , Descoberta de Drogas/métodos , Avaliação Pré-Clínica de Medicamentos/métodos , Ligantes , Modelos Moleculares , Compostos de Piridínio/química , Compostos de Piridínio/farmacologia , Relação Estrutura-Atividade
3.
ChemMedChem ; 13(24): 2653-2663, 2018 12 20.
Artigo em Inglês | MEDLINE | ID: mdl-30362667

RESUMO

The current standard therapy to counteract organophosphate intoxication is not effective in equal measure against all types of organophosphorus compounds (OPCs), as the outcome of oxime-induced reactivation of inactivated acetylcholinesterase (AChE) strongly depends on the particular OPC. In case the reactivation is insufficient, acetylcholine concentrations that rise to pathophysiological levels force the nicotinic acetylcholine receptor (nAChR) into a desensitized state and hence a functionally inactive state. As a consequence, neurotransmission is irreversibly disrupted at the neuromuscular junction. Previous electrophysiological studies identified the symmetric bispyridinium compound 1,1'-(propane-1,3-diyl)bis[4-(tert-butyl)pyridin-1-ium] diiodide (MB327) as a re-sensitizer of the desensitized nAChR. MB327 is thereby capable of restoring the functional activity. Very recently, in silico modeling studies suggested non-symmetric derivatives of MB327 as potential re-sensitizers with enhanced binding affinity and thus possible enhanced efficacy. In this study, 26 novel non-symmetric bispyridinium compounds and related derivatives were synthesized. For the synthesis of the highly polar target compounds in sufficient quantities, newly developed and highly efficient two-step procedures were used. Compounds were characterized in terms of their binding affinity toward the MB327 binding site at the nAChR using recently developed mass spectrometry (MS) Binding Assays. Regarding structure-affinity relationships at the MB327 binding site, the presence of two quaternary aromatic nitrogen centers as well as pyridinium systems with a tert-butyl group at the 4-position or a NMe2 group at the 3- or 4-positions appeared to be beneficial for high binding affinities.


Assuntos
Compostos de Piridínio/síntese química , Compostos de Piridínio/metabolismo , Receptores Nicotínicos/metabolismo , Animais , Sítios de Ligação , Humanos , Interações Hidrofóbicas e Hidrofílicas , Modelos Moleculares , Estrutura Molecular , Relação Estrutura-Atividade , Torpedo
4.
ChemMedChem ; 13(17): 1806-1816, 2018 09 06.
Artigo em Inglês | MEDLINE | ID: mdl-29974635

RESUMO

A novel series of 30 symmetric bispyridinium and related N-heteroaromatic bisquaternary salts with a propane-1,3-diyl linker was synthesized and characterized for their binding affinity at the MB327 binding site of nicotinic acetylcholine receptor (nAChR) from Torpedo californica. Compounds targeting this binding site are of particular interest for research into new antidotes against organophosphate poisoning, as therapeutically active 4-tert-butyl-substituted bispyridinium salt MB327 was previously identified as a nAChR re-sensitizer. Efficient access to the target compounds was provided by newly developed methods enabling N-alkylation of sterically hindered or electronically deactivated heterocycles exhibiting a wide variety of functional groups. Determination of binding affinities toward the MB327 binding site at the nAChR, using a recently developed mass spectrometry (MS)-based Binding Assay, revealed that several compounds reached affinities similar to that of MB327 (pKi =4.73±0.03). Notably, the newly prepared lipophilic 4-tert-butyl-3-phenyl-substituted bispyridinium salt PTM0022 (3 h) was found to have significantly higher binding affinity, with a pKi value of 5.16±0.07, thus representing considerable progress toward the development of more potent nAChR re-sensitizers.


Assuntos
Compostos de Piridínio/farmacologia , Receptores Nicotínicos/metabolismo , Animais , Sítios de Ligação/efeitos dos fármacos , Relação Dose-Resposta a Droga , Estrutura Molecular , Intoxicação por Organofosfatos/tratamento farmacológico , Compostos de Piridínio/síntese química , Compostos de Piridínio/química , Receptores Nicotínicos/química , Relação Estrutura-Atividade , Torpedo
5.
Toxicol Lett ; 293: 157-166, 2018 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-29191791

RESUMO

Organophosphorus compounds, including nerve agents and pesticides, exert their toxicity through irreversible inhibition of acetylcholinesterase (AChE) resulting in an accumulation of acetylcholine and functional impairment of muscarinic and nicotinic acetylcholine receptors. Current therapy comprises oximes to reactivate AChE and atropine to antagonize effects induced by muscarinic acetylcholine receptors. Nicotinic malfunction leading to depression of the central and peripheral respiratory system is not directly treated calling for alternative therapeutic interventions. In the present study, we investigated the electrophysiological properties of the human nAChR subtype α7 (hα7-nAChR) and the functional effect of the 4-tert-butyl bispyridinium (BP) compound MB327 and of a series of novel substituted bispyridinium compounds on the receptors by an automated patch clamp technique. Activation of hα7-nAChRs was induced by nicotine and acetylcholine demonstrating rapid cationic influx up to 100µM. Agonist-induced currents decayed within a few milliseconds revealing fast desensitization of the receptors. Application of higher agonist concentrations led to a decline of current amplitudes which seemed to be due to increasing receptor desensitization. When 100µM of agonist was coapplied with low concentrations of the well characterized α7-specific positive allosteric modulator PNU-120596 (1µM-10µM), the maximum response and duration of nAChR activation were markedly augmented indicating an elongated mean open-time of receptors and prevention of receptor desensitization. However, co-application of increasing PNU-120596 concentrations (>10µM) with agonist induced a decline of potentiated current responses. Although less pronounced than PNU-120596, six of the twenty tested substituted BP compounds, in particular those with a substituent at 3-position and 4-position at the pyridinium moieties, were found to potentiate current responses of hα7-nAChRs, most pronounced MB327.This effect was clearly depended on the presence of the agonist indicating a positive allosteric mechanism of these compounds. Besides potentiation at low concentrations, these compounds seem to interact at different binding sites on hα7-nAChRs since enhancement decreased at high concentrations. The residual fourteen BP compounds, possessing either an isopropyl-group or more than one group at the pyridinium moiety, antagonized nicotinic currents exhibiting IC50 of low up to high micromolar concentrations (∼1µM-300µM).


Assuntos
Compostos de Piridínio/química , Compostos de Piridínio/farmacologia , Receptor Nicotínico de Acetilcolina alfa7/efeitos dos fármacos , Animais , Células CHO , Cricetinae , Cricetulus , Relação Dose-Resposta a Droga , Fenômenos Eletrofisiológicos/efeitos dos fármacos , Isoxazóis/farmacologia , Agonistas Nicotínicos/farmacologia , Técnicas de Patch-Clamp , Compostos de Fenilureia/farmacologia , Relação Estrutura-Atividade
6.
Toxicol Lett ; 293: 184-189, 2018 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-29097222

RESUMO

Irreversible inhibition of the acetylcholine esterase upon intoxication with organophosphorus compounds leads to an accumulation of acetylcholine in the synaptic cleft and a subsequent desensitization of nicotinic acetylcholine receptors which may ultimately result in respiratory failure. The bispyridinium compound MB327 has been found to restore functional activity of nAChR thus representing a promising starting point for the development of new drugs for the treatment of organophosphate poisoning. In order to optimize the resensitizing effect of MB327 on nAChR, it would be very helpful to know the MB327 specific binding site to apply structure based molecular modeling. The binding site for MB327 at the nAChR is not known and so far goal of speculations, but it has been shown that MB327 does not bind to the orthosteric acetylcholine binding site. We have used docking calculations to screen the surface of nAChR for possible binding sites of MB327. The results indicate that at least two potential binding sites for MB327 at nAChR are present inside the channel pore. In these binding sites, MB327 intercalates between the γ-α and ß-δ subunits of nAChR, respectively. Both putative MB327 binding sites show an unsymmetrical distribution of surrounding hydrophilic and lipophilic amino acids. This suggests that substitution of MB327-related bispyridinium compounds on one of the two pyridinium rings with polar substituents should have a favorable effect on the pharmacological function.


Assuntos
Reativadores da Colinesterase/metabolismo , Reativadores da Colinesterase/farmacologia , Compostos de Piridínio/metabolismo , Compostos de Piridínio/farmacologia , Receptores Nicotínicos/efeitos dos fármacos , Acetilcolina/química , Animais , Sítios de Ligação/efeitos dos fármacos , Simulação por Computador , Modelos Moleculares , Simulação de Acoplamento Molecular , Estrutura Molecular , Intoxicação por Organofosfatos/tratamento farmacológico , Conformação Proteica , Torpedo
7.
Toxicol Lett ; 293: 149-156, 2018 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-29248576

RESUMO

Irreversible inhibition of acetylcholinesterase (AChE) resulting in accumulation of acetylcholine and overstimulation of muscarinic and nicotinic receptors accounts for the acute toxicity of organophosphorus compounds (OP). Accordingly, the mainstay pharmacotherapy against poisoning by OP comprises the competitive muscarinic acetylcholine receptor antagonist atropine to treat muscarinic effects and, in addition, oximes to reactivate inhibited AChE. A therapeutic gap still remains in the treatment of desensitized nicotinic acetylcholine receptors following OP exposure. Hereby, nicotinic effects result in paralysis of the central and peripheral respiratory system if untreated. Thus, these receptors pose an essential target for therapeutic indication to address these life-threatening nicotinic symptoms of the cholinergic crisis. Identification of ligands regulating dynamic transitions between functional states by binding to modulatory sites appears to be a promising strategy for therapeutic intervention. In this patch clamp study, the ability of differently substituted bispyridinium non-oximes to "resensitize" i.e. to recover the activity of desensitized human homomeric α7-type nAChRs stably transfected in CHO cells was investigated and compared to the already described α7-specific positive allosteric modulator PNU-120596. The structures of these bispyridinium analogues were based on the lead structure of the tert-butyl-substituted bispyridinium propane MB327, which has been shown to have a positive therapeutic effect due to a non-competitive antagonistic action at muscle-type nAChRs in vivo and has been found to have a positive allosteric activity at neuronal receptors in vitro. Prior to test compounds, desensitization of hα7-nAChRs was verified by applying an excess of nicotine revealing activation at low, and desensitization at high concentrations. Thereby, desensitization could be reduced by modulation with PNU-120596. Desensitization was further verified by dose-response profiles of agonists, carbamoylcholine and epibatidine in the absence and presence of PNU-120596. Although less pronounced than PNU-120596 and the lead structure MB327, bispyridinium compounds, particularly those substituted at position 3 and 4, resensitized the nicotine desensitized hα7-nAChRs in a concentration-dependent manner and prolonged the mean channel open time. In summary, identification of more potent compounds able to restore nAChR function in OP intoxication is needed for development of a putative efficient antidote.


Assuntos
Intoxicação por Organofosfatos/tratamento farmacológico , Compostos de Piridínio/farmacologia , Receptor Nicotínico de Acetilcolina alfa7/antagonistas & inibidores , Animais , Células CHO , Reativadores da Colinesterase/farmacologia , Cricetinae , Cricetulus , Relação Dose-Resposta a Droga , Humanos , Isoxazóis/uso terapêutico , Agonistas Nicotínicos/farmacologia , Técnicas de Patch-Clamp , Compostos de Fenilureia/uso terapêutico , Compostos de Piridínio/química , Relação Estrutura-Atividade , Receptor Nicotínico de Acetilcolina alfa7/agonistas
8.
Chemistry ; 18(13): 4051-62, 2012 Mar 26.
Artigo em Inglês | MEDLINE | ID: mdl-22367979

RESUMO

A large variety of twice-deprotonated nitrogen-rich 5,5'-bistetrazolates, that is, the ammonium (1), hydrazinium (2), hydroxylammonium (3), guanidinium (4), aminoguanidinium (5), diaminoguanidinium (6), triaminoguanidinium (7), and diaminouronium (8) salts, have been synthesized. Energetic compounds 1-8 were fully characterized by single-crystal X-ray diffraction (except 8), NMR spectroscopy, IR and Raman spectroscopy, and differential scanning calorimetry (DSC) measurements. With respect to their potential use in propellant applications, the sensitivity towards impact, friction, and electrical discharge were determined. Several propulsion and detonation parameters (e.g., heat of explosion, detonation velocity) were computed by using the EXPLO5 computer code based on calculated (CBS-4M) heats of formation and X-ray densities. Additionally, the performance of 1-8 in various formulations was investigated by calculating the specific energy and specific impulse of the compounds under isochoric conditions.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA